Research and Markets (http://www.researchandmarkets.com/research/xr3lb2/the_market_for) has announced the addition of the "The Market for Personalized Gene Therapy Treatments for Cancer" report to their offering.

This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach in cancer research. It involves modification of genes instead of using a surgical method or chemical drug product. Essentially, gene therapies replace an abnormal gene with a normal gene, or changes the response of a gene (turn on or off). Not all of the approaches to gene therapy are the same, and different cancers appear to respond better to different therapies.

Several gene therapy technologies have the ability to work in combination with other treatment options to enhance the effectiveness of a therapeutic regimen. Gene therapy is also designed to target specific cells making treatment much less damaging to healthy cells.

This report discusses those treatments and estimates market size and market potential for personalized medicine using gene therapy.

In addition the report provides:

  • Overview of Gene Therapy
  • Overall Market Size and Forecast
  • Cancer Therapeutic Market Totals
  • Discussion of Somati vs. Germ Line Gene Therapy
  • R&D Activities
  • Company Profiles

Key Topics Covered:

  1. Executive Summary
  2. Gene Therapy Overview
  3. Cancer and Gene Therapy
  4. Gene Therapy Outlook in Bladder Cancer
  5. Gene Therapy Outlook in Brain Cancer
  6. Gene Therapy Outlook in Breast Cancer
  7. Gene Therapy Outlook in Colorectal Cancer
  8. Gene Therapy Outlook in Head & Neck Cancer
  9. Gene Therapy Outlook in Leukemia
  10. Gene Therapy Outlook in Liver Cancer
  11. Gene Therapy Outlook in Lung Cancer
  12. Gene Therapy Outlook in Lymphoma
  13. Gene Therapy Outlook in Melanoma
  14. Gene Therapy Outlook in Ovarian Cancer
  15. Gene Therapy Outlook in Pancreatic Cancer
  16. Gene Therapy Outlook in Prostate Cancer
  17. Gene Therapy and Other Cancers
  18. Gene Therapy in Cancer Market Summary and Outlook
  19. Industry Participants and Contributors

Companies Mentioned

  • Advantagene, Inc.
  • Amgen, Inc.
  • Bellicum Pharmaceuticals, Inc.
  • BioCancell Ltd.
  • Blubird Bio
  • Celgene
  • Celsion Corporation
  • Chengdu Shi Endor Biological Engineering Technology Co., Ltd.
  • Cold Genesys, Inc.
  • Genprex, Inc.
  • MaxiVax SA
  • Momotaro-Gene, Inc.
  • MultiVir, Inc.
  • OncoSec Medical, Inc.
  • Sevion Therapeutics, Inc.
  • SynerGene Therapeutics, Inc.
  • Takara Bio, Inc.
  • Tocagen, Inc.
  • VBL Therapeutics Ltd.
  • Ziopharm Oncology, Inc.
  • daptimmune Ltd.

For more information visit http://www.researchandmarkets.com/research/xr3lb2/the_market_for